- Home
- KRMD vs LTH Comparison
KRMD vs LTH Comparison
Compare KRMD & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- LTH
- Stock Information
- Founded
- KRMD 1980
- LTH 1992
- Country
- KRMD United States
- LTH United States
- Employees
- KRMD N/A
- LTH N/A
- Industry
- KRMD Medical/Dental Instruments
- LTH Hotels/Resorts
- Sector
- KRMD Health Care
- LTH Consumer Discretionary
- Exchange
- KRMD Nasdaq
- LTH Nasdaq
- Market Cap
- KRMD 126.9M
- LTH N/A
- IPO Year
- KRMD N/A
- LTH 2021
- Fundamental
- Price
- KRMD $3.15
- LTH $28.45
- Analyst Decision
- KRMD Strong Buy
- LTH Buy
- Analyst Count
- KRMD 4
- LTH 12
- Target Price
- KRMD $4.63
- LTH $33.54
- AVG Volume (30 Days)
- KRMD 113.3K
- LTH 1.9M
- Earning Date
- KRMD 05-07-2025
- LTH 05-08-2025
- Dividend Yield
- KRMD N/A
- LTH N/A
- EPS Growth
- KRMD N/A
- LTH 174.52
- EPS
- KRMD N/A
- LTH 0.96
- Revenue
- KRMD $35,083,740.00
- LTH $2,730,319,000.00
- Revenue This Year
- KRMD $16.50
- LTH $13.85
- Revenue Next Year
- KRMD $15.47
- LTH $11.39
- P/E Ratio
- KRMD N/A
- LTH $29.88
- Revenue Growth
- KRMD 19.65
- LTH 18.58
- 52 Week Low
- KRMD $1.86
- LTH $14.52
- 52 Week High
- KRMD $5.05
- LTH $34.99
- Technical
- Relative Strength Index (RSI)
- KRMD 64.92
- LTH 39.70
- Support Level
- KRMD $2.51
- LTH $31.84
- Resistance Level
- KRMD $3.35
- LTH $34.99
- Average True Range (ATR)
- KRMD 0.19
- LTH 1.38
- MACD
- KRMD 0.09
- LTH -0.16
- Stochastic Oscillator
- KRMD 81.31
- LTH 3.40
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).